Philochem, a subsidiary of the Philogen Group, and Bracco Imaging announce that they have entered into a license and collaboration agreement to develop and commercialize a small organic molecule for imaging applications, with proven ability to selectively detect a variety of metastatic solid tumors in cancer patients, paving the way for a new approach to tumor diagnosis.
March 22, 2022
· 3 min read
